SCHEMBL8307843

SCHEMBL8307843

C(=NOCCOC1CCCCO1)c1cnc2ccccc2c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4C Q9H3R0 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.41
RAB9A P51151 3/20 0.41
NPC1 O15118 2/20 0.41
KMT2A Q03164 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
MEN1 O00255 2/20 0.39
ALDH1A1 P00352 2/20 0.39
MET P08581 2/20 0.39
PDGFRB P09619 1/20 0.37
PDGFRA P16234 1/20 0.37
KDM4E B2RXH2 1/20 0.36
ADORA2A P29274 1/20 0.35
DHFR P00374 1/20 0.33
CYP1A2 P05177 1/20 0.33
HPGD P15428 1/20 0.33
PRKAG1 P54619 1/20 0.33
PRKAA1 Q13131 1/20 0.33
HSD17B10 Q99714 1/20 0.33
PRKAB1 Q9Y478 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3076916 0.85 KDM4C (0.50) KDM4CL3MBTL1RAB9ANPC1KMT2A
SCHEMBL3076918 0.85 KDM4C (0.50) KDM4CL3MBTL1RAB9ANPC1KMT2A
SCHEMBL3083557 0.82 KDM4C (0.44) KDM4CL3MBTL1RAB9ANPC1KMT2A
SCHEMBL3083554 0.82 KDM4C (0.44) KDM4CL3MBTL1RAB9ANPC1KMT2A
SCHEMBL8304360 0.81 KDM4C (0.46) KDM4CL3MBTL1RAB9ANPC1KMT2A
SCHEMBL8304494 0.79 KDM4C (0.44) KDM4CL3MBTL1RAB9ANPC1KMT2A
SCHEMBL8309572 0.77 KDM4C (0.46) KDM4CL3MBTL1RAB9ANPC1KMT2A
SCHEMBL8305350 0.76 KDM4C (0.40) KDM4CL3MBTL1RAB9ANPC1KMT2A
SCHEMBL8307351 0.73 RAB9A (0.50) L3MBTL1RAB9ANPC1KMT2ASMN1; SMN2
SCHEMBL8307350 0.73 RAB9A (0.50) L3MBTL1RAB9ANPC1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5972959-A Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY, LIMITED (JP) 1999-10-26 US disclosed
EP-0708098-B1 Oxime derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1999-03-03 EP disclosed
US-5780490-A A O-(2,4-OXA(OR THIA)ZOLIDINYL)PHENYLOXY(OR THIO OR AMINO) ALKYLOXIME; ALDOSE REDUCTASE INHIBITORS; ANTIDIABETIC AND -HYPOGLYCEMIC AGENTS; LIVER, SKIN AND UROGENITAL DISORDERS SANKYO COMPANY, LIMITED (JP) 1998-07-14 US disclosed
US-5703096-A ANTIDIABETIC AGENTS; ALDOSE REDUCTASE INHIBITOR SANKYO COMPANY, LIMITED (JP) 1997-12-30 US disclosed
EP-0708098-A1 Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1996-04-24 EP disclosed